Organon Pharma Indonesia Tbk. vs Guna Timur Raya Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Guna Timur Raya Tbk. trades at Rp1,075 (market cap 374.1B, 3.49M 24h volume). The key difference: Guna Timur Raya Tbk. is far larger — about 3.6× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | TRUK | |
|---|---|---|
Market Cap | 104.4B | 374.1B |
Volume | — | 3.49M |
Lot | — | 34.89K |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT Guna Timur Raya (the Company) was established based on Notarial Deed No. 18 dated February 29, 1980 of Notary Jacinta Susanti, SH, under the name of PT Timur Jaya.
Read more on TRUK →